Chapter 22



1. Anon.  Clinical Practice Guidelines.  Available at:  Accessed July 5, 2008.


2. Doerler M, Hyun J, Venten I, Potthoff A, Bartke U, Serova K, Hoextermann S, Altmeyer P, Brockmeyer NH. Does chemosensitivity-assay-directed therapy have an influence on the prognosis of patients with malignant melanoma stage IV? A retrospective study of 14 patients with malignant melanoma stage IV.

Eur J Med Res. 2007 Oct 30;12(10):497-502


Bonnefoi H, Potti A, Delorenzi M, Mauriac L, Campone M, Tubiana-Hulin M, Petit T, Rouanet P, Jassem J, Blot E, Becette V, Farmer P, André S, Acharya CR, Mukherjee S, Cameron D, Bergh J, Nevins JR, Iggo RD. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial. Lancet Oncol. 2007 Dec;8(12):1071-8.


Lau GI, Loo WT, Chow LW. Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response. Biomed Pharmacother. 2007 Oct;61(9):562-5.


Nagourney RA.  Ex vivo programmed cell death and the prediction of response to chemotherapy.  Curr Treat Options Oncol. 2006 Mar;7(2):103-10


3. Dudek AZ, Mescher MF, Okazaki I, Math VT, Luo X, Curtsinger JM, Miller JS. Autologous large multivalent immunogen vaccine in patients with metastatic melanoma and renal cell carcinoma. Am J Clin Oncol. 2008 Apr;31(2):173-81.


Uemura H, De Velasco MA. Tumor vaccines in renal cell carcinoma. World J Urol. 2008 Apr;26(2):147-54.


Koido S, Hara E, Homma S, Fujise K, Gong J, Tajiri H. Dendritic/tumor fusion cell-based vaccination against cancer. Arch Immunol Ther Exp (Warsz). 2007 Sep-Oct;55(5):281-7.


4. Thorpe H, Brown SR, Sainsbury JR, Perren TJ, Hiley V, Dowsett M, Nejim A, Brown JM. Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: the ITS Study. Br J Cancer. 2008 Jan 15;98(1):39-44.


Kontos M, Fentiman IS.  Perioperatigve endocrine status and prognosis in early breast cancer.  Breast J. 2005; 12(6):518-25.


Wood PA, Hrushesky WJ. Sex cycle modulates cancer growth. Breast Cancer Res Treat. 2005 May;91(1):95-102.


Takeda Y, Nonaka Y, Yanagie H, Yoshizaki I, Eriguchi M. Correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal breast cancer patients. Biomed Pharmacother. 2001;55 Suppl 1:133s-137s.


Hrushesky WJ. Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer. J Natl Cancer Inst. 2002 Nov 20;94(22):1720


Hagen AA, Hrushesky WJ. Menstrual timing of breast cancer surgery. Am J Surg. 1998 Mar;175(3):245-61.


5. Wood PA, Bove K, You S, Chambers A, Hrushesky WJ. Cancer growth and spread are saltatory and phase-locked to the reproductive cycle through mediators of angiogenesis. Mol Cancer Ther. 2005 Jul;4(7):1065-75.


6. Devine EC. Effects of psychoeducational care for adult surgical patients: a meta-analysis of 191 studies. Patient Educ Couns. 1992 Apr;19(2):129-42.


Astin JA. Mind-body therapies for the management of pain. Clin J Pain. 2004 Jan-Feb;20(1):27-32.


7. Vulink A, Radford KJ, Melief C, Hart DN. Dendritic cells in cancer immunotherapy.

Adv Cancer Res. 2008;99:363-407.


8. Kidd PM.  The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev. 2000 Feb;5(1):4-27.


Cao LZ, Lin ZB. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol Lett. 2002 Oct 1;83(3):163-9.


Kodama N, Murata Y, Nanba H. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice. J Med Food. 2004 Summer;7(2):141-5.


Harada N, Kodama N, Nanba H.  Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett. 2003 Mar 31;192(2):181-7.


Kanazawa M, Mori Y, Yoshihara K, Iwadate M, Suzuki S, Endoh Y, Ohki S, Takita K, Sekikawa K, Takenoshita S. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunol Lett. 2004 Feb 15;91(2-3):229-38.


Thomas R. Lipsky PE.  Dendritic cells: origin and differentiation. Stem Cells. 14(2):196-206, 1996


Cao LX, Lin ZB.  Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides.  Immunol Lett 2002; 83(3):163-9.


Takei M, Tachikawa E, Hasegawa H, Lee JJ. Dendritic cells maturation promoted by M1 and M4, end products of steroidal ginseng saponins metabolized in digestive tracts, drive a potent Th1 polarization. Biochem Pharmacol. 2004 Aug 1;68(3):441-52.


Lee JK. Lee MK. Yun YP. Kim Y. Kim JS. Kim YS. Kim K. Han SS. Lee CK. Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells. International Immunopharmacology. 1(7):1275-84, 2001


Peng SY. Norman J. Curtin G. Corrier D. McDaniel HR. Busbee D. Decreased mortality of Norman murine sarcoma in mice treated with the immunomodulator, Acemannan. Molecular Biotherapy. 3(2):79-87, 1991.


9. Stehr SN, Heller AR. Omega-3 fatty acid effects on biochemical indices following cancer surgery. Clin Chim Acta. 2006 Nov;373(1-2):1-8.


Calder PC. n-3 fatty acids, inflammation, and immunity--relevance to postsurgical and critically ill patients. Lipids. 2004 Dec;39(12):1147-61.


Liang B, Wang S, Ye YJ, Yang XD, Wang YL, Qu J, Xie QW, Yin MJ. Impact of postoperative omega-3 fatty acid-supplemented parenteral nutrition on clinical outcomes and immunomodulations in colorectal cancer patients. World J Gastroenterol. 2008 Apr 21;14(15):2434-2439.


10. Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett. 2008;



Ravindranath MH, Muthugounder S, Presser N, Viswanathan S. Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol. 2004;546:121-65.


Schindler R, Mentlein R. Flavonoids and vitamin E reduce the release of the angiogenic peptide vascular endothelial growth factor from human tumor cells. J Nutr. 2006 Jun;136(6):1477-82.


Buteau-Lozano H, Velasco G, Cristofari M, Balaguer P, Perrot-Applanat M. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism. J Endocrinol. 2008 Feb;196(2):399-412.


11. Ho JC, Konerding MA, Gaumann A, Groth M, Liu WK. Fungal polysaccharopeptide inhibits tumor angiogenesis and tumor growth in mice. Life Sci. 2004 Jul 30;75(11):1343-56.


12. Kim JH, Lee EO, Lee HJ, Ku JS, Lee MH, Yang DC, Kim SH. Caspase activation and extracellular signal-regulated kinase/Akt inhibition were involved in luteolin-induced apoptosis in Lewis lung carcinoma cells. Ann N Y Acad Sci. 2007 Jan;1095:598-611.


Bagli E, Stefaniotou M, Morbidelli L, Ziche M, Psillas K, Murphy C, Fotsis T.

Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity. Cancer Res. 2004 Nov 1;64(21):7936-46.


Hasebe Y, Egawa K, Yamazaki Y, Kunimoto S, Hirai Y, Ida Y, Nose K. Specific inhibition of hypoxia-inducible factor (HIF)-1 alpha activation and of vascular endothelial growth factor (VEGF) production by flavonoids. Biol Pharm Bull. 2003 Oct;26(10):1379-83.


13. Shankar S, Ganapathy S, Hingorani SR, Srivastava RK. EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Front Biosci. 2008 Jan 1;13:440-52.


Yamakawa S, Asai T, Uchida T, Matsukawa M, Akizawa T, Oku N. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett. 2004 Jul 8;210(1):47-55.


14. Singh RP, Sharma G, Mallikarjuna GU, Dhanalakshmi S, Agarwal C, Agarwal R.

In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):244-50.


Rizvi I, Riggs DR, Jackson BJ, Ng A, Cunningham C, McFadden DW. Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma. J Surg Res. 2006 Jun 1;133(1):3-6.


15. Lee A, Chui PT, Aun CS, Lau AS, Gin T. Incidence and risk of adverse perioperative events among surgical patients taking traditional Chinese herbal medicines. Anesthesiology. 2006 Sep;105(3):454-61.


Hodges PJ, Kam PC. The peri-operative implications of herbal medicines. Anaesthesia. 2002 Sep;57(9):889-99.


16. Cheng B, Hung CT, Chiu W. Herbal medicine and anaesthesia. Hong Kong Med J. 2002 Apr;8(2):123-30.


Lyons TR. Herbal medicines and possible anesthesia interactions. AANA J. 2002 Feb;70(1):47-51.


17. Kamenícek V, Holán P, Franĕk P. [Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling]. Acta Chir Orthop Traumatol Cech. 2001;68(1):45-9.


Sun J, Guo W, Ben Y, Jiang J, Tan C, Xu Z, Wang X, Bai C. Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats.

Crit Care Med. 2008 Apr;36(4):1205-13.


Satoskar RR, Shah SJ, Shenoy SG. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol. 1986 Dec;24(12):651-4.


18. Arnberger M, Stadelmann K, Alischer P, Ponert R, Melber A, Greif R. Monitoring of neuromuscular blockade at the P6 acupuncture point reduces the incidence of  postoperative nausea and vomiting. Anesthesiology. 2007 Dec;107(6):903-8. 


Kim Y, Kim CW, Kim KS. Clinical observations on postoperative vomiting treated by auricular acupuncture. Am J Chin Med. 2003;31(3):475-80.


Dundee JW, McMillan CM. Clinical uses of P6 acupuncture antiemesis. Acupunct Electrother Res. 1990;15(3-4):211-5.


Streitberger K, Ezzo J, Schneider A. Acupuncture for nausea and vomiting: an update of clinical and experimental studies. Auton Neurosci. 2006 Oct 30;129(1-2):107-17.


19. White B. Ginger: an overview.  Am Fam Physician. 2007 Jun 1;75(11):1689-91.


Ciocon JO, Ciocon DG, Galindo DJ. Dietary supplements in primary care. Botanicals can affect surgical outcomes and follow-up. Geriatrics. 2004 Sep;59(9):20-4.


20. Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879-923.


Sacerdote P, Bianchi M, Gaspani L, Manfredi B, Maucione A, Terno G, Ammatuna M, Panerai AE. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 2000 Jun;90(6):1411-4